{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:05:47Z","timestamp":1794330347714,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T00:00:00Z","timestamp":1429228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0928-6","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T09:04:17Z","timestamp":1429175057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME\u212210, a new liposomal amphotericin B"],"prefix":"10.1186","volume":"15","author":[{"given":"Mohammad","family":"Asad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradyot","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antara","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,17]]},"reference":[{"key":"928_CR1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671.","journal-title":"PLoS One"},{"key":"928_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1590\/S0036-46652009000500002","volume":"51","author":"H Goto","year":"2009","unstructured":"Goto H, Prianti M. Immunoactivation and immunopathogeny during active visceral leishmaniasis. Rev Inst Med Trop Sao Paulo. 2009;51:241\u20136.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"928_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.16943\/ptinsa\/2014\/v80i2\/55105","volume":"80","author":"A Md","year":"2014","unstructured":"Md A, Ali N. Dynamicity of immune regulation during visceral leishmaniasis. Proc Indian Natl Sci Acad. 2014;80:247\u201367.","journal-title":"Proc Indian Natl Sci Acad"},{"key":"928_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1590\/0037-8682-0022-2012","volume":"46","author":"P Bhattacharya","year":"2013","unstructured":"Bhattacharya P, Ali N. Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis. Rev Soc Bras Med Trop. 2013;46:128\u201334.","journal-title":"Rev Soc Bras Med Trop"},{"key":"928_CR5","first-page":"245","volume":"123","author":"S Saha","year":"2006","unstructured":"Saha S, Mondal S, Banerjee A, Ghose J, Bhowmick S, Ali N. Immune responses in kala-azar. Indian J Med Res. 2006;123:245\u201366.","journal-title":"Indian J Med Res"},{"key":"928_CR6","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1586\/eri.10.78","volume":"8","author":"S Mondal","year":"2010","unstructured":"Mondal S, Bhattacharya P, Ali N. Current diagnosis and treatment of visceral leishmaniasis. Expert Rev Anti Infect Ther. 2010;8:919\u201344.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"928_CR7","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.4049\/jimmunol.179.8.5592","volume":"179","author":"S Saha","year":"2007","unstructured":"Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, Mallick S, et al. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol. 2007;179:5592\u2013603.","journal-title":"J Immunol"},{"key":"928_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1586\/eri.12.148","volume":"11","author":"SA Ejazi","year":"2013","unstructured":"Ejazi SA, Ali N. Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects. Expert Rev Anti Infect Ther. 2013;11:79\u201398.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"928_CR9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0035-9203(99)90036-6","volume":"93","author":"PV Bodhe","year":"1999","unstructured":"Bodhe PV, Kotwani RN, Kirodian BG, Pathare AV, Pandey AK, Thakur CP, et al. Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1999;93:314\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"928_CR10","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1371\/journal.pntd.0000764","volume":"4","author":"S Mondal","year":"2010","unstructured":"Mondal S, Bhattacharya P, Rahaman M, Ali N, Goswami RP. A curative immune profile one week after treatment of Indian kala-azar patients predicts success with a short-course liposomal amphotericin B therapy. PLoS Negl Trop Dis. 2010;4:e764.","journal-title":"PLoS Negl Trop Dis"},{"key":"928_CR11","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1517\/14656566.6.16.2821","volume":"6","author":"S Sundar","year":"2005","unstructured":"Sundar S, Rai M. Treatment of visceral leishmaniasis. Expert Opin Pharmacother. 2005;6:2821\u20139.","journal-title":"Expert Opin Pharmacother"},{"key":"928_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/sj.bmt.1702243","volume":"25","author":"GJ Timmers","year":"2000","unstructured":"Timmers GJ, Zweegman S, Simoons-Smit AM, van Loenen AC, Touw D, Huijgens PC. Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial. Bone Marrow Transplant. 2000;25:879\u201384.","journal-title":"Bone Marrow Transplant"},{"key":"928_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.molbiopara.2003.10.002","volume":"133","author":"TJ Pucadyil","year":"2004","unstructured":"Pucadyil TJ, Tewary P, Madhubala R, Chattopadhyay A. Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. Mol Biochem Parasitol. 2004;133:145\u201352.","journal-title":"Mol Biochem Parasitol"},{"key":"928_CR14","first-page":"1567","volume":"3","author":"AKS Chandel","year":"2014","unstructured":"Chandel AKS, Panthi B, Ranawat B. Impact of cholesterol on Leishmania parasites culture and in-vitro assessment of cytokine profile in Leishmania primed macrophage of healthy person. World J Pharm Pharm Sci. 2014;3:1567\u201384.","journal-title":"World J Pharm Pharm Sci"},{"key":"928_CR15","volume-title":"Sterol enriched mixed lamelarity amphotericin intercalating liposomes in saline and the process for their preparation","author":"JN Verma","year":"2005","unstructured":"Verma JN, Verma L, Tripathi KK. Sterol enriched mixed lamelarity amphotericin intercalating liposomes in saline and the process for their preparation. 2005. Patent Number WO\/2005\/120460."},{"key":"928_CR16","first-page":"767","volume":"137","author":"J Mishra","year":"2013","unstructured":"Mishra J, Dey A, Singh N, Somvanshi R, Singh S. Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model. Indian J Med Res. 2013;137:767\u201376.","journal-title":"Indian J Med Res"},{"key":"928_CR17","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/iai.65.6.2371-2377.1997","volume":"65","author":"F Afrin","year":"1997","unstructured":"Afrin F, Ali N. Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes. Infect Immun. 1997;65:2371\u20137.","journal-title":"Infect Immun"},{"key":"928_CR18","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.4049\/jimmunol.181.2.1386","volume":"181","author":"A Banerjee","year":"2008","unstructured":"Banerjee A, De M, Ali N. Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses. J Immunol. 2008;181:1386\u201398.","journal-title":"J Immunol"},{"key":"928_CR19","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1128\/AAC.00524-10","volume":"55","author":"A Banerjee","year":"2011","unstructured":"Banerjee A, De M, Ali N. Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation. Antimicrob Agents Chemother. 2011;55:1661\u201370.","journal-title":"Antimicrob Agents Chemother"},{"key":"928_CR20","doi-asserted-by":"publisher","first-page":"e17376","DOI":"10.1371\/journal.pone.0017376","volume":"6","author":"J Roychoudhury","year":"2011","unstructured":"Roychoudhury J, Sinha R, Ali N. Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB\/c mice. PLoS One. 2011;6:e17376.","journal-title":"PLoS One"},{"key":"928_CR21","first-page":"251","volume":"3","author":"R Kumar","year":"2012","unstructured":"Kumar R, Nylen S. Immunobiology of visceral leishmaniasis. Front Immunol. 2012;3:251.","journal-title":"Front Immunol"},{"key":"928_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1517\/13543784.17.5.787","volume":"17","author":"S Sundar","year":"2008","unstructured":"Sundar S, Chakravarty J. Paromomycin in the treatment of leishmaniasis. Expert Opin Investig Drugs. 2008;17:787\u201394.","journal-title":"Expert Opin Investig Drugs"},{"key":"928_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","volume":"377","author":"S Sundar","year":"2011","unstructured":"Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, et al. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet. 2011;377:477\u201386.","journal-title":"Lancet"},{"key":"928_CR24","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","volume":"17","author":"SL Croft","year":"2011","unstructured":"Croft SL, Olliaro P. Leishmaniasis chemotherapy\u2013challenges and opportunities. Clin Microbiol Infect. 2011;17:1478\u201383.","journal-title":"Clin Microbiol Infect"},{"key":"928_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0167-7799(00)89017-4","volume":"13","author":"G Gregoriadis","year":"1995","unstructured":"Gregoriadis G. Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol. 1995;13:527\u201337.","journal-title":"Trends Biotechnol"},{"key":"928_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/0255-0857.96703","volume":"30","author":"K Pandey","year":"2012","unstructured":"Pandey K, Pun SB, Pandey BD. Relapse of kala-azar after use of multiple drugs: a case report and brief review of literature. Indian J Med Microbiol. 2012;30:227\u20139.","journal-title":"Indian J Med Microbiol"},{"key":"928_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s11096-011-9544-8","volume":"33","author":"N Kumar","year":"2011","unstructured":"Kumar N, Sinha PK, Pandey K, Verma N, Lal CS, Ranjan A, et al. A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy. Int J Clin Pharm. 2011;33:726\u20139.","journal-title":"Int J Clin Pharm"},{"key":"928_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/515085","volume":"28","author":"A Meyerhoff","year":"1999","unstructured":"Meyerhoff A. U.S. Food and Drug Administration approval of Am Bisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis. 1999;28:42\u20138. discussion 49\u201351.","journal-title":"Clin Infect Dis"},{"key":"928_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1128\/AAC.30.6.847","volume":"30","author":"JD Berman","year":"1986","unstructured":"Berman JD, Hanson WL, Chapman WL, Alving CR, Lopez-Berestein G. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob Agents Chemother. 1986;30:847\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"928_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/08982109309150726","volume":"3","author":"FC Szoka","year":"1993","unstructured":"Szoka FC, mad Tang M. Liposome. J Liposome Res. 1993;3:363\u201375.","journal-title":"J Liposome Res"},{"key":"928_CR31","first-page":"1101","volume":"128","author":"G Hernandez","year":"2000","unstructured":"Hernandez G, Altermatt F, Bernucci F, Acuna D, Apablaza F, Valenzuela F, et al. [Use of amphotericin B in lipid emulsions: does it prevent its toxicity in critically ill patients?]. Rev Med Chil. 2000;128:1101\u20137.","journal-title":"Rev Med Chil"},{"key":"928_CR32","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1365-3156.2008.02128.x","volume":"13","author":"S Sundar","year":"2008","unstructured":"Sundar S, Chakravarty J, Agarwal D, Shah A, Agrawal N, Rai M. Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar. Trop Med Int Health. 2008;13:1208\u201312.","journal-title":"Trop Med Int Health"},{"key":"928_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parint.2013.09.016","volume":"63","author":"H Sachdeva","year":"2014","unstructured":"Sachdeva H, Sehgal R, Kaur S. Asparagus racemosus ameliorates cisplatin induced toxicities and augments its antileishmanial activity by immunomodulation in vivo. Parasitol Int. 2014;63:21\u201330.","journal-title":"Parasitol Int"},{"key":"928_CR34","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1128\/AAC.47.12.3774-3779.2003","volume":"47","author":"M Larabi","year":"2003","unstructured":"Larabi M, Yardley V, Loiseau PM, Appel M, Legrand P, Gulik A, et al. Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B. Antimicrob Agents Chemother. 2003;47:3774\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 4","key":"928_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1469-0691.2008.01984.x","volume":"14","author":"F Lanternier","year":"2008","unstructured":"Lanternier F, Lortholary O. Liposomal amphotericin B: what is its role in 2008? Clin Microbiol Infect. 2008;14 Suppl 4:71\u201383.","journal-title":"Clin Microbiol Infect"},{"key":"928_CR36","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/clinids\/22.6.938","volume":"22","author":"RN Davidson","year":"1996","unstructured":"Davidson RN, di Martino L, Gradoni L, Giacchino R, Gaeta GB, Pempinello R, et al. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clin Infect Dis. 1996;22:938\u201343.","journal-title":"Clin Infect Dis"},{"key":"928_CR37","doi-asserted-by":"publisher","first-page":"e35670","DOI":"10.1371\/journal.pone.0035670","volume":"7","author":"PK Kushawaha","year":"2012","unstructured":"Kushawaha PK, Gupta R, Tripathi CD, Sundar S, Dube A. Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein\/vaccine candidate against visceral Leishmaniasis. PLoS One. 2012;7:e35670.","journal-title":"PLoS One"},{"key":"928_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fcimb.2012.00069","volume":"2","author":"C Bogdan","year":"2012","unstructured":"Bogdan C. Natural killer cells in experimental and human leishmaniasis. Front Cell Infect Microbiol. 2012;2:69.","journal-title":"Front Cell Infect Microbiol"},{"key":"928_CR39","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.4049\/jimmunol.154.9.4623","volume":"154","author":"HW Ghalib","year":"1995","unstructured":"Ghalib HW, Whittle JA, Kubin M, Hashim FA, el-Hassan AM, Grabstein KH, et al. IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol. 1995;154:4623\u20139.","journal-title":"J Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0928-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0928-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T14:08:40Z","timestamp":1691590120000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0928-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["928"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0928-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,17]]},"assertion":[{"value":"16 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"188"}}